Memphasys Share Price and Company Fundamentals



Price
$0.054
Change
-0.002 (-3.571%)
52 week
0.05 - 0.16

Last traded: Today at 5:54 AM

Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.

Key Metrics

PE ratio

-

PB ratio

4.50

Dividend yield

Beta

-0.32

Market cap

$41.03M

Enterprise value

$42.66M

Company profile

Primary activitiesMemphasys Limited (ASX:MEM) specialises in biological separations for commercial applications. The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained.
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.memphasys.com
Mailing address30 Richmond Road Homebush NSW 2140 Australia
Phone / Fax61 2 8415 7300 / 61 2 8415 7399
Share registryBOARDROOM PTY LIMITED

Dividends

Memphasys does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Memphasys.

NameTitleAgeTotal Pay
Ms. Alison Mary Coutts B.E., M.B.A., B.E. (Chem), GDipBiotech, MBAExec. Chairman & Interim CEO315.67k
Pablo NeyertzDirector of Fin.155.08k
Nick GorringOperations Mang.144.1k
Mr. Malcolm ColemanChief Financial Officer of Nusep Ltd
Mr. Andrew MetcalfeCompany Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Return on assets

-6.89%

Return on equity

-11.55%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Memphasys is 41.03M and its enterprise value is 42.66M.

Companies similar to Memphasys (MEM)

Memphasys (ASX:MEM) Frequently Asked Questions

1. What is Memphasys's Stock Symbol?

Memphasys trades on ASX under the ticker symbol "MEM".

2. What is Memphasys's stock price today?

One share of MEM stock can currently be purchased for approximately $0.054.

3. How can I contact Memphasys?

Memphasys's mailing address is 30 Richmond Road Homebush NSW 2140 Australia. The company can be reached via phone at 61 2 8415 7300.

4. What is Memphasys's official website?

The official website of Memphasys is http://www.memphasys.com.

5. Which share registry manages Memphasys's stock?

Memphasys's stock is managed by BOARDROOM PTY LIMITED.